Document is current

Any future updates will be listed below

A real world experience with fingolimod in active RRMS patients naïve to second-line agents: a 2 years, intention-to-treat, observational, single center study

Crossref DOI link: https://doi.org/10.1186/s40893-016-0002-2

Published Online: 2016-04-01

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark